Pomerantz Law Firm Initiates Class Action Against DENTSPLY SIRONA Inc. Over Claims of Securities Fraud
Class Action Alert: DENTSPLY SIRONA Inc. Faces Legal Challenges
The Pomerantz Law Firm has officially announced a class action lawsuit against DENTSPLY SIRONA Inc., a notable name in the dental product industry, under the ticker symbol XRAY. The legal action stems from allegations that the company engaged in securities fraud and other dubious business practices. The lawsuit has significant implications for shareholders affected by DENTSPLY's tumultuous recent history, particularly following alarming announcements about its product lines and financial forecasts.
On December 3, 2024, Pomerantz LLP revealed the class action and urged investors to get in touch for further details. Interested shareholders are encouraged to reach out to Danielle Peyton at Pomerantz to discuss their potential claims. Individuals who've purchased or acquired shares of DENTSPLY during the designated Class Period have until January 27, 2025, to make a request for appointment as Lead Plaintiff, allowing them to take the lead in this legal battle.
The controversy began with DENTSPLY's acquisition of Byte, a well-known manufacturer of clear dental aligners, for a staggering $1.04 billion in cash on December 31, 2020. Recent developments, however, have raised serious questions regarding this acquisition. On October 24, 2024, DENTSPLY announced a suspension of sales and marketing for its Byte products, citing concerns related to regulatory compliance. They described this pause as a